Necrotizing Ulcerative Gingivitis Treatment Market Trends

  • Report ID: 3596
  • Published Date: Apr 04, 2023
  • Report Format: PDF, PPT

Necrotizing Ulcerative Gingivitis Treatment Market Trends

Growth Drivers

  • Growing Prevalence of NUG and Other Oral Diseases with Lack of Awareness among People – Most people across the world do not consider dental problems as a major issue owing to a lack of knowledge. The presence of only fluoride water and the use of fluoride toothpaste for a longer time is also estimated to cause oral problems. Also, many low-income countries have less education regarding oral health and low or no spending capacity for healthcare. Additionally, the increasing age also causes many oral issues such as gum swelling, tooth decay, cavities, damaged teeth, and plaque formation which are left untreated.

As per the data from the Centers for Disease Control and Prevention in 2019, 1 in 5 people in the U.S. which is over 25% of the adult population are living with untreated dental cavities.

  • High Cases of Diabetes and Other Lifestyle Diseases with Poor Eating Habits – The incidence of diabetes increases the risk of worsening wounds and any other injuries as they are immune suppressed. The number of people diagnosed with diabetes in the U.S. was estimated to be over 28 million i.e., ~11% population, and more than 37 million people which is ~9% population had diabetes in 2019.

  • Growing Consumption of Tobacco and Other Related Products – More than 80% of people across the world who use tobacco are estimated to be present in low and middle-income countries as of 2022. 

  • Increasing Population with Habits of Drinking Alcohol Across the World – Alcohol contains fermented bacteria that is used for the fermentation of alcohol which gets deposited on the teeth every time you drink.  The percentage of people who binge drink alcohol as of 2020 was estimated to be over 20% in the U.S. and more than 6.5% of American people developed alcohol use disorder (AUD).

  • High Number of People Suffering from Nutritional Deficiencies – Lack of vitamin B12, iron, niacin, and vitamin B13 and low availability of essential nutrients is estimated to lead to gingivitis. The number of people suffering from undernourishment increased to more than 130 million people across the world during 2019-2022.

Challenges

  • Lack of Awareness Regarding Oral Health Hygiene –

Not everyone is worried about decayed teeth until it bothers with pain, swelling, and bleeding. People neglect oral hygiene as it does not affect them very much and poverty in many countries is also estimated to hinder the growth of the market in the coming years.

  • Long Term Intake of Antibiotics Builds Resistance
  • Presence of Discomfort and Bleeding During the Treatment Procedure

Necrotizing Ulcerative Gingivitis (NUG) Treatment Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~12%

Base Year Market Size (2022)

~ USD 894 Million

Forecast Year Market Size (2035)

~ USD 2184 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3596
  • Published Date: Apr 04, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing incidences of oral diseases, and poor diet and dental hygiene are the major factors driving the market growth.

The market size of necrotizing ulcerative gingivitis (NUG) treatment is anticipated to attain a CAGR of ~12% over the forecast period, i.e., 2023-2035.

Lack of health awareness amongst people and discomfort during treatment procedures are estimated to be the growth hindering factors for the market expansion

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics Limited, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by treatment, distribution channel, and by region.

The medication segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying